Android app on Google Play

Goldman Sachs Adds Baxter International (BAX) to Conviction Buy List, Sees 28% Upside

June 19, 2012 7:01 AM EDT Send to a Friend
Get Alerts BAX Hot Sheet
Price: $74.98 +0.09%

Rating Summary:
    8 Buy, 11 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade BAX Now!
Join SI Premium – FREE
Goldman Sachs added Baxter International (NYSE: BAX) to its Conviction Buy List and lifted its price target to $64.00 (from $63.00), implying 28% upside.

The firm notes that due to a new product delay, concerns over increased competition in key franchises, and FX, shares are down 16.5 percent since April 1, versus the 4.5 percent slide in the S&P 500. Goldman, however, sees several pipeline products driving accelerating topline growth and a dividend increase in the 2nd-half.

In addition, shares traded at a trough multiple at 10.2X 2013E EPS, just above the level following the 2010 downturn in the plasma market.

For an analyst ratings summary and ratings history on Baxter International click here. For more ratings news on Baxter International click here.

Shares of Baxter International closed at $49.92 yesterday.




You May Also Be Interested In


Related Categories

Hot Upgrades, Upgrades

Related Entities

Goldman Sachs Conviction Buy List, Goldman Sachs, Standard & Poor's, Dividend

Add Your Comment